BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 15011246)

  • 21. Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI.
    Su MY; Baik HM; Yu HJ; Chen JH; Mehta RS; Nalcioglu O
    Technol Cancer Res Treat; 2006 Aug; 5(4):401-10. PubMed ID: 16866570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
    Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
    Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume.
    Oh J; Henry RG; Pirzkall A; Lu Y; Li X; Catalaa I; Chang S; Dillon WP; Nelson SJ
    J Magn Reson Imaging; 2004 May; 19(5):546-54. PubMed ID: 15112303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas.
    Catalaa I; Henry R; Dillon WP; Graves EE; McKnight TR; Lu Y; Vigneron DB; Nelson SJ
    NMR Biomed; 2006 Jun; 19(4):463-75. PubMed ID: 16763973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma.
    Stadlbauer A; Buchfelder M; Doelken MT; Hammen T; Ganslandt O
    Cent Eur Neurosurg; 2011 May; 72(2):63-9. PubMed ID: 20635312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers.
    Marcus KJ; Astrakas LG; Zurakowski D; Zarifi MK; Mintzopoulos D; Poussaint TY; Anthony DC; De Girolami U; Black PM; Tarbell NJ; Tzika AA
    Int J Oncol; 2007 Mar; 30(3):651-7. PubMed ID: 17273766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.
    Möller-Hartmann W; Herminghaus S; Krings T; Marquardt G; Lanfermann H; Pilatus U; Zanella FE
    Neuroradiology; 2002 May; 44(5):371-81. PubMed ID: 12012120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting regions with highest lipid content on MR spectroscopy may improve diagnostic yield in stereotactic biopsy.
    Ng WH; Lim T
    J Clin Neurosci; 2008 May; 15(5):502-6. PubMed ID: 18334298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation.
    Rees J; Watt H; Jäger HR; Benton C; Tozer D; Tofts P; Waldman A
    Eur J Radiol; 2009 Oct; 72(1):54-64. PubMed ID: 18632238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation and follow-up outcome of diffusion tensor imaging-based functional neuronavigation: a prospective, controlled study in patients with gliomas involving pyramidal tracts.
    Wu JS; Zhou LF; Tang WJ; Mao Y; Hu J; Song YY; Hong XN; Du GH
    Neurosurgery; 2007 Nov; 61(5):935-48; discussion 948-9. PubMed ID: 18091270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes in 1H-MRS in glioma patients before and after irradiation: the significance of quantitative analysis of choline-containing compounds].
    Isobe T; Matsumura A; Anno I; Nagatomo Y; Yoshizawa T; Itai Y; Nose T
    No Shinkei Geka; 2003 Feb; 31(2):167-72. PubMed ID: 12616652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
    Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of feature-reduced MR spectroscopic and MR imaging data for improved brain tumor classification.
    Simonetti AW; Melssen WJ; Szabo de Edelenyi F; van Asten JJ; Heerschap A; Buydens LM
    NMR Biomed; 2005 Feb; 18(1):34-43. PubMed ID: 15657908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results.
    Di Costanzo A; Trojsi F; Giannatempo GM; Vuolo L; Popolizio T; Catapano D; Bonavita S; d'Angelo VA; Tedeschi G; Scarabino T
    J Exp Clin Cancer Res; 2006 Sep; 25(3):383-90. PubMed ID: 17167979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monovoxel 1H magnetic resonance spectroscopy in the progression of gliomas.
    Alimenti A; Delavelle J; Lazeyras F; Yilmaz H; Dietrich PY; de Tribolet N; Lövblad KO
    Eur Neurol; 2007; 58(4):198-209. PubMed ID: 17823533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate.
    Fütterer JJ; Scheenen TW; Heijmink SW; Huisman HJ; Hulsbergen-Van de Kaa CA; Witjes JA; Heerschap A; Barentsz JO
    Invest Radiol; 2007 Feb; 42(2):116-22. PubMed ID: 17220729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectrum separation resolves partial-volume effect of MRSI as demonstrated on brain tumor scans.
    Su Y; Thakur SB; Karimi S; Du S; Sajda P; Huang W; Parra LC
    NMR Biomed; 2008 Nov; 21(10):1030-42. PubMed ID: 18759383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Automatic glioma characterization from dynamic susceptibility contrast imaging: brain tumor segmentation using knowledge-based fuzzy clustering.
    Emblem KE; Nedregaard B; Hald JK; Nome T; Due-Tonnessen P; Bjornerud A
    J Magn Reson Imaging; 2009 Jul; 30(1):1-10. PubMed ID: 19557840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of in vivo proton MR spectroscopy in the evaluation of adult brain lesions: our preliminary experience.
    Kumar A; Kaushik S; Tripathi RP; Kaur P; Khushu S
    Neurol India; 2003 Dec; 51(4):474-8. PubMed ID: 14742925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D 1H MRSI of brain tumors at 3.0 Tesla using an eight-channel phased-array head coil.
    Osorio JA; Ozturk-Isik E; Xu D; Cha S; Chang S; Berger MS; Vigneron DB; Nelson SJ
    J Magn Reson Imaging; 2007 Jul; 26(1):23-30. PubMed ID: 17659562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.